Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/37147
Title: | Endoplasmic reticulum stress markers in SARS-COV-2 infection and pneumonia: Case-control study | Authors: | Köseler, A. Sabirli, R. Gören, T. Türkçüer, İbrahim Kurt, Ö. |
Keywords: | Endoplasmic reticulum stress GRP78 Pneumonia SARS-COV-2 biological marker glucose regulated protein 78 growth arrest and DNA damage inducible protein 153 protein kinase protein kinase RNA like endoplasmic reticulum kinase unclassified drug Article clinical article controlled study coronavirus disease 2019 endoplasmic reticulum stress enzyme blood level enzyme linked immunosorbent assay human protein blood level virus pneumonia |
Publisher: | International Institute of Anticancer Research | Abstract: | Background/Aim: A novel human coronavirus, named SARS-COV-2, has recently caused thousands of deaths all around the world. Endoplasmic reticulum (ER) stress plays an important role in the development of diseases. Patients and Methods: We aimed to to investigate the relationship between ER stress markers in patients infected with SARS-COV-2 and patients with pneumonia. A total of 9 patients (4 patients diagnosed with pneumonia and 5 patients diagnosed with SARS-COV-2 infection) who admitted to the emergency Department with symptoms of pneumonia and SARS-COV-2 were included in the study. A total of 18 healthy individuals without any known chronic or acute disease and drug use were included as the healthy control group. Serum human glucose regulated protein 78 (GRP78), serum human C/EBP homologous protein (CHOP) and serum human phospho extracellular signal regulated kinase (PERK) levels were measured using enzyme-linked immunosorbent assay (ELISA). Results: GRP78 levels were found to be significantly higher in SARS-COV-2 positive cases compared to individuals in other groups. Serum GRP- 78 level median value was statistically significantly higher in SARS-COV-2-positive group compared to the other groups (p=0.0003). Serum PERK level was statistically significantly higher in SARS-COV-2-positive pneumonia cases (p=0.046). Conclusion: An association was shown between GRP78 and SARS-COV-2 infection. Although a small number of patients was investigated, these results will be important and guide future treatments of SARS-COV-2. © 2020 International Institute of Anticancer Research. All rights reserved. | URI: | https://hdl.handle.net/11499/37147 https://doi.org/10.21873/invivo.11956 |
ISSN: | 0258-851X |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
1645.full.pdf | 265.83 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
51
checked on Dec 21, 2024
WEB OF SCIENCETM
Citations
50
checked on Dec 20, 2024
Page view(s)
32
checked on Aug 24, 2024
Download(s)
18
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.